Atorvastatin Efficacy and Safety in Patients With Ulcerative Colitis

PHASE2RecruitingINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

February 1, 2023

Primary Completion Date

June 1, 2026

Study Completion Date

September 20, 2027

Conditions
Inflammatory Bowel Diseases
Interventions
DRUG

Atorvastatin 80mg

Atrovastatin is one of the most effective drugs used to reduce intracellular cholesterol synthesis. it exerts numerous pleiotropic effects including anti-inflammatory, antioxidant properties, endothelial function improvement and immunomodulation independent of its basic lipid-lowering properties

DRUG

Mesalamine

Mesalamine

Trial Locations (1)

35511

RECRUITING

Faculty of Medicine, Mansoura University, Al Mansurah

All Listed Sponsors
lead

Tanta University

OTHER